Abstracts

HIV-INFECTED MACROPHAGES EVADE NK CELL-MEDIATED KILLING WHILE DRIVING INFLAMMATION

The primary targets for HIV infection are CD4+ T cells, however macrophages also become infected and persist despite antiretroviral therapy, suggesting evasion of immune responses. Our previous work shows that while HIV-infected macrophages are recognized by cytolytic CD8+ T lymphocytes (CTL), killing is inefficient due to resistance to CTL-derived granzymes. This poor killing delays CTL…

HIV DNA DETECTED IN IMMUNE CELL SUBSETS IN CSF DURING ART

HIV-infected cells persist in the central nervous system (CNS) in at least half of people with HIV (PWH) on antiretroviral therapy (ART). We previously reported on a novel population of myeloid lineage microglia-like cells in cerebrospinal fluid (CSF) from PWH on ART; however the identity of CNS cells containing proviruses remains unknown. Fresh CSF and…

EFFECTS OF HIV AND AGING ON RESTING-STATE NETWORKS

Despite the use of combination antiretroviral therapy, many HIV associated conditions, such as HIV associated neurocognitive disorders and frailty still exist in people living with HIV (PLWH). A potential biomarker reflective of these conditions is resting state functional connectivity (rsFC). Changes in rsFC strength have been hypothesized to reflect a compensatory reaction due to damage…

PROSPECTIVE ENHANCED MONITORING OF DOLUTEGRAVIR-BASED FIRST LINE IN MALAWI

In January 2019 the Ministry of Health of Malawi rolled-out tenofovir-lamivudine-dolutegravir (TLD) as national first-line antiretroviral therapy (ART). Transitioning of patients already on non-nucleoside-reverse-transcriptase-inhibitor-(NNRTI) first line was without prior HIV-1 viral load (VL) testing. VL monitoring and drug resistance testing (DRT) are still in scale-up in Malawi. In parallel to the national ART policy change,…